Get started
Author

Bengisu Dayanc

ORCID: 0000-0003-4451-7178
Observed ORCID: 0000-0003-4451-7178
OpenAlex ID: A5043934034
The Jekyll and Hyde of Cellular Senescence in Cancer
2021 · Dilara Demirci, Bengisu Dayanc, et al. · Cells · 58
PDF
Integrative multi-omics identifies AP-1 transcription factor as a targetable mediator of acquired osimertinib resistance in non-small cell lung cancer
2025 · Bengisu Dayanc, Sude Eris, et al. · Cell Death and Disease · 17
PDF
Engineering and validation of a dual luciferase reporter system for quantitative and systematic assessment of regulatory sequences in Chinese hamster ovary cells
2022 · Yagmur Toktay, Bengisu Dayanc, et al. · Scientific Reports · 14
PDF
Escape from TGF ‐β‐induced senescence promotes aggressive hallmarks in epithelial hepatocellular carcinoma cells
2025 · Minenur Kalyoncu, Dilara Demirci, et al. · Molecular Oncology · 1
Leveraging Circular Polymerization and Extension Cloning (CPEC) Method for Construction of CRISPR Screening Libraries
2024 · Bengisu Dayanc, Sude Eris, et al. · BIO-PROTOCOL · 1
Correction: Integrative multi-omics identifies AP-1 transcription factor as a targetable mediator of acquired osimertinib resistance in non-small cell lung cancer
2026 · Bengisu Dayanc, Sude Eris, et al. · Cell Death and Disease
PDF
Challenges in First-Line Osimertinib Therapy in EGFR-Mutant Non-small Cell Lung Cancer: Acquired Resistance Is the Issue
2022 · Bengisu Dayanc, Sude Eris, et al. · Interdisciplinary cancer research
Modulation of glucocorticoid ınduced tumor necrosis factor receptor (GITR)-gıtr ligand (GITRL) ınteraction in breast cancer cells under the control of ataxia telangiectasia mutated (ATM) promoter
2017 · Bengisu Dayanc
Works count: 8
Citation count: 91
H-index: 3
I10-index: 3
Year
Topic
Type